Product logins

Find logins to all Clarivate products below.


Laparoscopic Devices | Market Insights | Europe (Supplemental) | 2022

While the COVID-19 pandemic has had a negative impact on the US laparoscopic device market and the overall healthcare system in the US, the US laparoscopic market will nonetheless expand modestly through 2030. This will be driven by an expanding patient base and rising laparoscopic and robotic-assisted procedure volumes. Market expansion will be driven by increasing adoption of advanced premium-priced technologies including direct energy devices, powered staplers, and 4k video laparoscopes; however, limited reimbursement will hinder the overall market to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic devices in the US across a 11-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…